Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

NCT06931405 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inducible Urticaria
Chronic Spontaneous Urticaria

Interventions

DRUG: BLU-808
DRUG: Placebo

Sponsor

Blueprint Medicines Corporation